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Sphere Formation Permits Oct4 Reprogramming
of Ciliary Body Epithelial Cells
into Induced Pluripotent Stem Cells
Aiguo Ni, Ming Jing Wu, and Sai H. Chavala
Somatic cells can be reprogrammed to induced pluripotent stem (iPS) cells by defined sets of transcription
factors. We previously described reprogramming of monolayer-cultured adult mouse ciliary body epithelial
(CE) cells by Oct4 and Klf4, but not with Oct4 alone. In this study, we report that Oct4 alone is sufficient to
reprogram CE cells to iPS cells through sphere formation. Furthermore, we demonstrate that sphere formation
induces a partial reprogramming state characterized by expression of retinal progenitor markers, upregulation of
reprogramming transcription factors, such as Sall4 and Nanog, demethylation in the promoter regions of
pluripotency associated genes, and mesenchymal to epithelial transition. The Oct4-iPS cells maintained normal
karyotypes, expressed markers for pluripotent stem cells, and were capable of differentiating into derivatives of
all three embryonic germ layers in vivo and in vitro. These findings suggest that sphere formation may render
somatic cells more susceptible to reprogramming.
Introduction
The ciliary body is a region that harbors ocular cellsthat are easily surgically accessible, and are of interest
for regenerative ophthalmology [1–4]. The surface of the
ciliary body is composed of a series of ridges called ciliary
processes. The ciliary processes are covered by a specialized
epithelium that is of neuroepithelial origin.
Sphere formation assays in a serum-free medium were
first described as a method to select and expand stem cells
[5,6]. Previous studies demonstrated that primary ciliary
body epithelial (CE) cells have the ability to form clonal
neurospheres, suggesting stem cells-like cells residing in
the ciliary body epithelium [7]. CE sphere-derived cells
expressed some retinal stem/progenitor cell markers in the
culture [7,8]. However, the expression seems to be induced
by growth factors in the medium. It remains unclear if these
cells are bona fide quiescent retinal stem cells [8,9].
Generation of induced pluripotent stem (iPS) cells
through ectopic expression of defined transcription factors
holds great potential for regenerative medicine and disease
modeling [10]. We previously found that mouse CE-derived
cells, grown in monolayer cultures, express Sox2, Klf4, and
c-Myc, and that these monolayer CE cells can be repro-
grammed into iPS cells with ectopic Oct4 and Klf4 (2F), but
not with Oct4 alone [1]. Given that adult neural stem cells,
capable of sphere formation, have been previously repro-
grammed into iPS cells with Oct4 alone [11,12], and that CE
cells have the remarkable plasticity to form spheres dis-
playing certain characteristics of neuroepithelial progenitors




All procedures on mice were performed in accordance
with the ARVO Statement for the Use of Animals in Oph-
thalmic and Vision Research and approved by the Institu-
tional Animal Care and Use Committee at the University of
North Carolina at Chapel Hill. Wild-type (WT) CD-1 strain
mice, aged 5–6 weeks, were used for the study.
CE spheres and monolayer cultures
Dissection of adult mouse ciliary body was performed
as previously described [7]. Dissociated cells were resus-
pended in a serum-free growth medium (SFM) containing
Neurobasal medium, 1· B27 supplement, 1% penicillin/
streptomycin, 2 mM l-glutamine, 20 ng/mL basic fibroblast
growth factor (Peprotech), 20 ng/mL epidermal growth
factor (Peprotech), and 2 mg/mL heparin (Sigma). To gen-
erate floating spheres, CE cells were plated at a density of 20
cells per microliter in ultra-low attachment 24-well plates
(Corning) [8]. To establish monolayer cultures, cells were
grown in SFM supplemented with 1% fetal bovine serum
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(FBS) as previously described [1]. The medium was chan-
ged every 3 days. All cell culture reagents were from In-
vitrogen, unless otherwise noted.
Induction of iPS cells
The procedure of iPS cells generation was essentially as
previously described with minor modifications [1]. In brief,
all spheres at day 7 were dissociated into single cells with
Accutase (Sigma) and plated at 1 · 105 cells per well of
gelatin-coated six-well plates in 1% FBS-containing SFM.
CE monolayer cultures at passage 2 (7 days after isolation)
were plated the same as above. The next day, for the two-
factor transduction, concentrated lentiviruses contain-
ing CMV promoter-driven human Oct4 and Klf4 or Sall4
(Cellomics Technology) were added to the cells at a mul-
tiplicity of infection of 10 with 4 mg/mL polybrene (Sigma)
in 1% FBS-containing SFM, whereas for the one-factor
transduction, only lentivirus coding human Oct4 was added.
Twenty-four hours post infection, the viral infection mix
was exchanged for fresh 1% FBS-containing SFM. The
following day, transduced cells were subcultured onto mi-
tomycin C-treated SNL feeder cells (Cell Biolabs) in six-
well plates at a split ratio of 1:4 in embryonic stem (ES) cell
medium minus leukemia inhibitory factor (LIF) containing
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 15% FBS, 2 mM l-glutamine, 100mM non-
essential amino acids, 100mM 2-mercaptoethanol, 50 U/mL
penicillin, and 50 mg/mL streptomycin [13]. At day 21,
the ES cell medium was replaced with serum-free N2B27
medium supplemented with LIF and 2i inhibitors [14],
CHIR99021 (3mM; Stemgent), and PD0325901 (1 mM;
Stemgent). After another 7 days, ES cell-like colonies were
picked and dissociated with trypsin and expanded on SNL
feeders in KnockOut DMEM supplemented with 15%
knockout serum replacement (KSR), 100 mM minimum es-
sential medium (MEM) non-essential amino acids, 100mM
2-mercaptoethanol, 2 mM l-glutamine, 50 U penicillin, and
50 mg/mL streptomycin [15].
The efficiency of generating iPS cells was calculated by
dividing the number of alkaline phosphatase (or Nanog)-
positive ES cell-like colonies by the seeded cell number.
Viral vector integration analysis
Genomic DNA was isolated with the Quick-gDNA Mini-
Prep (Zymo Research) according to the manufacturer’s in-
structions. Genomic polymerase chain reaction (PCR) was
performed as previously described [1].
Karyotyping
Karyotyping was performed by KaryoLogic, Inc. (http://
karyologic.com/).
Bisulfite genomic sequencing
Bisulfite sequencing and DNA methylation analysis was
performed as previously described [1]. Briefly, genomic
DNA was prepared with Quick-gDNA MiniPrep (Zymo
Research) and treated with the EZ DNA Methylation-
Lightning Kit (Zymo Research) according to the manufac-
turer’s instructions. Previously published nested primer sets
were used to amplify the promoter regions of the genes:
Sox2, Nanog, and Oct4 [16,17]. Amplified fragments were
cloned using the Zero Blunt TOPO PCR Cloning Kits (In-
vitrogen). Individual clones (10 or more) were sequenced
with the SP6 and T7 primers.
RNA isolation, reverse transcription–polymerase
chain reaction, and real-time PCR
Total RNA was isolated from the cells with the Direct-zol
RNA MiniPrep (Zymo Research) with DNase I digestion.
Total RNA of mouse ES-D3 cell line was purchased from
Cell Biolabs. Complementary DNA was synthesized with
Superscript III First-Strand Synthesis System (Invitrogen).
PCR and Real-time PCR were performed as previously
described [1]. Previously published primer sets were used
[1,9,18,19]. The mRNA level of target gene was normalized
to the housekeeping gene HPRT.
Immunofluorescence staining and alkaline
phosphatase staining
Immunofluorescence staining was performed as previously
described [1]. Briefly, fixed cells were treated with a blocking
solution, followed by an overnight incubation with the primary
antibodies at 4C. After rinsing with phosphate-buffered sa-
line, the cells were incubated with secondary antibodies, rinsed
and counter-stained with Hoechst 33342. iPS cells were also
stained with an Alkaline Phosphatase Staining Kit (Stemgent)
following the manufacturer’s instructions.
In vitro differentiation and teratoma formation
In vitro differentiation and teratoma formation were
performed as previously described [1].
Statistics
In all real-time PCR experiments, n = 3. P-value was
calculated using the Student’s t-test.
Results/Discussion
We isolated CE cells from ciliary body of CD1 WT
mice, and cultured them as free-floating spheres in SFM
(Fig. 1A). In agreement with previous studies [7–9], our
reverse transcription–polymerase chain reaction (RT-PCR)
analysis revealed that the expression of retinal progenitor
markers such as Pax6, Sox2, Rax, Otx2, Lhx2, Six3, and
nestin were induced in the culture in the sphere and
monolayer cells, whereas differentiated ciliary epithelial
marker Palmdelphin (Palmd) remained stable in the sphere,
but decreased in the monolayer, and another ciliary epithe-
lial transcript Tyrosinase (Tyr) decreased progressively in
the sphere and monolayer (Fig. 1B). Together, these results
suggested that CE cells acquired neural progenitor proper-
ties following culturing in mitogen-containing SFM.
Next, we reprogrammed CE sphere-derived cells with
ectopic Oct4 and Klf4 (2F), and with Oct4 alone (Fig. 2A).
At day 21 after infection, we observed ES cell-like colonies
in 2F-transduced CE sphere-derived cells and about 44 al-
kaline phosphatase-positive colonies (44/100,000) after an-
other 7 days, with a reprogramming efficiency close to the
2F control experiment using CE monolayer culture as de-
scribed previously [1]. However, with Oct4 alone, no iPS
3066 NI, WU, AND CHAVALA
cell colonies emerged, even after another 14 days. As de-
scribed previously in the 1F experiment using CE monolayer
culture, some morphological changes occurred, suggesting a
partially reprogrammed state. When switching to serum-free
N2B27 medium with dual inhibition (2i) of glycogen syn-
thase kinase-3 and mitogen-activated protein kinase signal-
ing at day 21 post infection, one ES cell-like colony (Fig. 2B,
left) appeared at day 28 after infection from 100,000 seeded
CE sphere-derived cells, with a reprogramming efficiency of
0.001% at day 35 (1/100,000, three times). In contrast, in the
parallel 1F experiment using CE monolayer culture, iPS cell
colonies were never observed, even with more initially pla-
ted cells (Fig. 2B, right, 0/106, two times).
All of the three picked 1F colonies could be further ex-
panded for more than 20 passages in serum-free N2B27
medium supplemented with 2i/LIF, displaying proliferation
and a morphology characteristic of ES cells (Fig. 3A) and
maintaining alkaline phosphatase activity (Fig. 3B). 1F-iPS
cells were confirmed to have only Oct4 transgene by ge-
nomic PCR (Fig. 3C), suggesting that ectopic Sox2, Klf4,
and c-Myc are dispensable for reprogramming CE sphere-
derived cells into iPS cells. The established 1F-iPS cell lines
were then further characterized. They expressed all tested
endogenous pluripotency markers, as detected by RT-PCR
(Fig. 3D), whereas the transgene hOct4 was significantly
attenuated at late passages (Fig. 3E). With immunofluores-
cence staining, we confirmed transcription markers such as
Oct4, Sox2, and Nanog, and pluripotent cell surface marker
SSEA-1 (Fig. 3F). DNA methylation pattern in Oct4 and
Nanog promoters in 1F-iPS cells were similar to that in
embryonic stem cells (ESCs) (Fig. 3G). In addition, 1F-iPS
cells maintained a normal karyotype (Fig. 3H). We next
evaluated the differentiation potential of 1F-iPS cells in
vitro. 1F-iPS cells effectively formed embryoid bodies (EB)
(Fig. 3I). Ten days after EB transfer onto gelatin-coated
plates, the attached cells expressed markers of three germ
layers, including the ectoderm markers Nefl and Nestin, the
mesoderm markers KDR, FLT1, and T (Brachyury), and the
endoderm markers Foxa2 and GATA4 as determined by
RT-PCR (Fig. 3J). To fully characterize the differentiation
potential in vivo, we injected 1F iPS cells into immune-
deficient NOD-SCID mice. Histological examinations
showed that the generated teratomas contained derivatives of
all three embryonic germ layers (Fig. 3K). We confirmed
these morphological findings with immunofluorescence
staining: neural epithelial-like tissues (ectoderm) were posi-
tive for tubulin-b III expression, muscle-like tissues (meso-
derm) were positive for a-smooth muscle actin, and gut-like
epithelium (endoderm) was positive for E-cadherin expres-
sion (Fig. 3L). These observations suggested that the 1F iPS
cells were fully reprogrammed into pluripotency.
To better understand why sphere formation makes CE
cells amendable to 1F reprogramming, we evaluated mRNA
expression of some key pluripotency-associated genes and
genes involved in mesenchymal–epithelial transition (MET)
by quantitative RT-PCR (Fig. 4A). Neither the CE sphere
nor the monolayer culture expresses Oct4 at appreciable
levels. Sox2 expression was high, but almost at the same
level. Although Prdm14, Esrrb, and Dppa2 expression was
FIG. 1. Mouse ciliary body epithelial (CE)
cell culture. (A) Brightfield image of a 7-day
old CE sphere. (B) Reverse transcription–
polymerase chain reaction (RT-PCR) showed
that the expression of retinal progenitor
markers, Pax6, Sox2, Rax, Otx2, Lhx2, Six3,
and nestin, were induced in culture in the
sphere and monolayer cells, whereas the
differentiated CE marker Palmd remained
stable in the sphere, but decreased in the
monolayer, and another CE transcript Tyr
decreased progressively in the sphere and
monolayer (lane 1, CE tissue; lane 2, 4-day
old sphere; lane 3, 7-day old sphere; lane 4,
7-day old monolayer).
FIG. 2. Generation of induced pluripotent stem (iPS) cells
from CE sphere-derived cells with reprogramming factor
Oct4. (A) Timeline for reprogramming CE sphere-derived
cells into iPS cells. CE sphere-derived cells were transduced
with Oct4. Transduction mix was exchanged for fresh
growth medium at day 1. At day 2 transduced cells were
subcultured onto SNL feeder cells in embryonic stem cell
medium minus leukemia inhibitory factor (LIF). At day 21,
the medium was switched to 2i-medium. (B) Representative
1F iPS colony from CE sphere-derived cells (left) and
negative control from CE monolayer (right).
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FIG. 3. Characterization of 1F iPS cells. (A) Representative 1F-iPS cell line cultured in the N2B27 + 2i/LIF medium. (B)
Alkaline phosphatase staining of representative 1F-iPS cell line. (C) Genotyping of 1F iPS cells. Genomic PCR showed only
Oct4 transgene in the three 1F-iPS cell lines (1F01, 1F02, and 1F03) as expected. 4F-iPS cells (4F02) were used as control.
(D) RT-PCR of pluripotency-associated genes and HPRT. 1F-iPS cells express all tested endogenous pluripotency genes as
mouse embryonic stem cells (D3), and parental CE sphere-derived cells (CE-s) express Sox2, Klf4, and c-Myc. (E) Ex-
pression of the transgene hOct4 is significantly attenuated in late passage 1F03 iPS cells. RT-quantitative PCR for the mRNA
of viral hOct4 in wild-type CE sphere (CE-S), mouse ES D3 line, and 1F03 iPS cells at passage 5 (1F03p5) and passage 15
(1F03P15). (F) Immunostaining of pluripotency markers Oct4, Sox2, Nanog, and SSEA-1 in 1F03 iPS cells. Scale bar,
100mm. (G) Methylation analysis of the Oct4 and Nanog promoters in ES (E14) and 1F03 iPS cells. Bisulfite sequencing of
the Oct4 and Nanog promoters revealed that CpGs in the parental CE cells (Fig. 4B) were converted to a demethylated state
in the 1F03 iPS cells resulting in a methylation pattern similar to that of mouse ES cells. Open circles indicate unmethylated
CpG. (H) Karyotyping analysis of 1F03 iPS cells revealed their female karyotypes with normal chromosomal stability/
integrity. (I) Embryoid bodies derived from 1F03 iPS cells. (J) RT-PCR of typical lineage markers after differentiation of
embryoid bodies from 1F03F iPS clones. (K) Teratoma formation. Hematoxylin and eosin staining of teratoma sections
derived from 1F iPS clones showed all three embryonic germ layers. (L) Immunostaining of teratoma sections showed
tubulin-b III positive neural epithelium, a-smooth muscle actin-positive muscle and E-cadherin-positive endodermal cells.
Scale bar, 100mm. Color images available online at www.liebertpub.com/scd
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increased, the expression levels of Sall4, c-Myc, Lin28,
Glis1, Klf4, and Nanog were most significantly upregulated
in the sphere compared with the monolayer. Combination of
these factors with or without Oct4 has been shown to suc-
cessfully reprogram mouse embryonic fibroblasts to iPS
cells [20–22]. Recently, Sall4 was identified as one of the
two most induced genes (the other Sox2) in the early phase
in response to the seven small molecule combination in a
chemical reprogramming that efficiently drives iPS cells
reprogramming in mouse somatic cells [18]. To assess
whether Sall4 could enhance 1F-Oct4 reprogramming, we
asked if overexpression of Sall4 in the CE monolayer with
Oct4 could generate iPS cells. Surprisingly, we did not ob-
serve any ES-like colonies, which we performed twice. This
suggests that additional mechanisms are responsible for the
reprogramming advantage observed with CE spheres. Since
we determined that CE monolayer could be reprogrammed
with 2F (Klf4 and Oct4), we propose that upregulation of
Klf4, or genes that can replace Klf4 function, can circumvent
the requirement of Klf4. Indeed we found that Klf4, and Esrrb,
Glis1 and Prdm14, which have been shown to replace Klf4 in
reprogramming [21,23,24], were upregulated by CE sphere
formation. Whether the upregulation of these genes is re-
sponsible for 1F-Oct4 reprogramming of CE sphere-derived
FIG. 4. Gene expression in the CE sphere and monolayer. (A) Quantitative real-time PCR was performed on the primary
CE sphere (7 days old) and CE monolayer (passage 2 at 7 days after isolation). Neither of the cells expresses Oct4 at
appreciable levels. Compared with the CE monolayer (set as 0), expression levels of Sox2, Klf4, c-Myc, Nanog, Lin28,
Esrrb, Dppa2, Prdm14, Glis1, Sall4, Dnmt3a, Dnmt3b, Tet1, Tet2, Cdh1, Epcam, Zo-1, Ocln, Zeb1, Zeb2, Snail, Tgfb1,
Tgfb2, Tgfbr1, Bmpr2, Smad1, and Smad4 are increased in the CE sphere. Data are normalized for HPRT expression and
presented as mean – standard error of the means for three replicates. *P value < 0.05; **P value < 0.01. (B) Methylation
patterns of the Sox2, Nanog, and Oct4 gene promoters were analyzed using bisulfate-treated DNA from the CE sphere (CE-
S) and the CE monolayer (CE-M). Closed circles indicate methylated CpG and open circles indicate unmethylated CpG.
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cells requires further investigation. It is, however, tempting to
speculate that one step of sphere formation might reduce the
small molecule number and speed up the reprogramming
process in a chemical reprogramming of CE spheres since
Sox2 expression is already high or induced by sphere forma-
tion (Figs. 1B and 3D). Two de novo DNA methyltransferases,
Dnmt3a and Dnmt3b, and the 10–11 Translocation-family
demethylases, Tet1 and Tet2, were also expressed higher in the
sphere, suggesting changes in DNA methylation during sphere
formation [25]. In agreement with this observation, bisulfite
sequencing evaluating the methylation status in the promoter
regions of Oct4, Nanog, and Sox2 revealed that the methyla-
tion in CE spheres was lower than those in monolayer cells
(Fig. 4B), indicating these genes were more transcriptionally
activated than monolayer cells. Cdh1 and Epcam, which are
beneficial to iPS cell generation [19,26], were higher in the CE
sphere. However, the difference could result from down-
regulation of Cdh1 and Epcam in the monolayer due to the
presence of transforming growth factor-b (TGF-b) in serum-
containing medium. To rule out this possibility, we grew CE
cells in the same serum-containing medium for mono-
layer culture, but in ultra-low attachment plates. Under such
a condition, CE cells formed spheres, and Cdh1 and Epcam
were still significantly expressed higher in the spheres
(Supplementary Fig. S1; Supplementary Data are available
online at www.liebertpub.com/scd). We then checked the
expression of other MET genes in the CE culture. Genes
encoding TGF-b pathway members (TGFB1, TGFB2,
TGFBR1, Zeb1, Zeb2, and Snail, except for Slug) were all
upregulated by sphere formation, whereas tested epithelial
genes (ZO-1 and OCLN) and BMP pathway members
(BMPR2, SMAD1, and SMAD4) were also upregulated.
This suggests a BMP-driven MET could occur during sphere
formation similar to the initiation phase of fibroblast re-
programming to pluripotency [19]. Together, these findings
support the notion that sphere formation induces MET. We
hypothesize that this transition may be conducive to iPS cell
generation through a sequential EMT–MET mechanism as
described previously [27,28].
In this study, we show sphere formation partially repro-
grams CE cells, and provides an iPS reprogramming ad-
vantage. Our observation may be applicable to other cell
types such as fibroblasts. Previous studies have shown that
forced growth of fibroblasts into spheres caused MET and
induced stem cell/progenitor properties [29,30].
In summary, we demonstrated in this study that through
sphere formation, Oct4 alone can reprogram CE sphere-
derived cells into pluripotent stem cells. Sphere formation
reprograms CE cells to progenitor-like cells with the ex-
pression of neural stem cell markers and upregulation of
various reprogramming factors compared with the mono-
layer. These findings suggest a two-step reprogramming
scheme, in which the first step of sphere formation induces
somatic cells into a partially reprogrammed stage, followed
by reduced ectopic input for iPS cell reprogramming.
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